Identification of impurities

Infrared absorption spectra can be employed for the identification of pure compounds or for the detection and identification of impurities. Most of the applications are concerned with organic compounds, primarily because water, the chief solvent for inorganic compounds, absorbs strongly beyond 1.5//m. Moreover, inorganic compounds often have broad absorption bands, whereas organic substances may give rise to numerous narrower bands. 

There are generally two types of analyses that are requested with reference to solvents. The first is the identification of residual solvents in products, and the second is the identification of impurities in common industrial solvents. Certain GC conditions have been found to separate most of the common solvents. Always examine the mass spectra at the front and back of the GC peaks to determine if they are homogeneous. Also remember that isomers may not be detected by this approach if they are not separated. 

Luminescence spectroscopy is one of the most sensitive techniques for identification of impurities in dyes. The most commonly observed impurities in to-bipyridyl complexes of the type [RuL2X2] are the homoleptic tris-bipyridyl species [RuL3]2+. Since the emission quantum yields of the [RuL3]2+ complexes are significantly higher than those of the [RuL2X2] complexes, one can identify the homoleptic impurities at a level of less than 1%. This does depend, however, on the relative quantum yields, and position of the emission spectral maxima, for the complexes and impurities involved. 

Once a database is established, it is made available to other laboratories through the company s secured intranet, so that the information therein can be updated, retrieved and reviewed. The resulting structural library can be referenced throughout the lifetime of the drug for rapid identification of impurities, degradants, and metabolites. 

LC-NMR is a powerful technique especially for the analysis of compounds which cannot be isolated by preparative HPLC. For the identification of impurities in API from unpublished work from this laboratory, impurities at a 1% level from drug substances can be identified on a 600 MHz NMR spectrometer using the stop-flow mode. 

Statistical analysis" has demonstrated that the demands placed upon the reliability of the chemical shift predictions intrinsic in this automated confirmation of structure, are greater if predicted and experimental stoichiometries cannot be compared. Furthermore, it is inevitable that high throughput environments will not yield pure compounds and the reliable identification of impurities (identified as fractional stoichiometry) will be key. 

Capillary zone electrophoresis (CZE) is the most common electrophoretic separation technique due to its simplicity of operation and its flexibility. It is the standard mode for drug analysis, identification of impurities, and pharmacokinetic studies. Other separation modes, such as capillary isotachopho-resis (CITP), micellar electrokinetc chromatography (MEKC), capillary electrochromatography (CEC), capillary gel electrophoresis (CGE), capillary isoelectric focusing, and affinity capillary electrophoresis (ACE), have then-advantages in solving specific separation problems, since the separation mechanism of each mode is different. 

The technique of mass spectrometry (MS) is itself of no help in the detection of impurities, but in combination with gas chromatography (the GC-MS technique) it would be the method of choice for the identification of impurities. 

MS delivers both information about the mass and the isotope pattern of a compound and can be used for the structural analysis upon performance of MS/MS experiments. Therefore, it is a valuable tool for the identification and characterization of an analyte as well as for the identification of impurities. Potential applications are the identification of IL in fhe quality control or in environmental studies. Unwanted by-products formed during the s)mthe-sis or by the hydrolysis of components of the ILs can be identified by this method. The analysis of fhe IL itself is also a prerequisite for the analysis of compounds dissolved in fhese media, as will be ouflined in the section 14.4. Beside the identification of fhe ILs, a characterization of different properties like water miscibility and the formation of ion clusfers, providing valuable information abouf fhe molecular structure of the IL, can be performed by means of MS techniques. The majority of studies reported up to now have dealt with ILs encompassing substituted imidazolium or pyridinium cations, therefore fhe following discussion concentrates on these compounds unless otherwise stated. 

At the other extreme, public interest groups could argue that any discovery that benefits society in any way should be considered as innovation. Thus, a routine toxicological test that develops new information about a compound would be innovation. Identification of impurities associated with a compound would be innovation. Epidemiological studies would be innovations. 

A laser-induced ToF mass spectrometer (LIMA-2A) was manufactured by Cambridge Mass Spectrometry Ltd., Cambridge, UK, for micro local analysis and was used to analyze thin sections of biological samples in the transmission mode or bulk material in the reflection mode.150,151 Typical LIMA applications in microelectronics include identification of impurities in dielectrics, microlocal analysis, depth profiling, thick film analysis and investigations on hybrid circuits. 

Identification of impurities at grain boundaries is one of the most straightforward uses of AES. However, analysis of fractured surfaces does have three potential problem areas. First, it... 

The type and extent of preclinical and clinical studies should be determined on a case-by-base basis. Establishing comparability among biologic products generally requires a full characterization of physico-chemical properties, identification of impurities, and quantification of biologic activity with both in-vitro and in-vivo testing. Because of the inherent variability of biologic processes, batch-to-batch consistency must also be ensured. If quality attributes (e. g., purity, potency, identity, and stability) cannot be adequately assessed with analytic studies, then preclinical and/or clinical studies will likely be needed. 

The preclinical stage of drug development focuses on activities necessary for filing an IND/CTA. The completed IND/CTA contains information that details the drug s composition and the synthetic processes used for its production. The IND/CTA also contains animal toxicity data, protocols for early phase clinical trials, and an outline of specific details and plans for evaluation. Process research, formulation, metabolism, and toxicity are the major areas of responsibility in this development stage. Analysis activities that feature LC/MS primarily focus on the identification of impurities, de-gradants, and metabolites. 

With an increasing number of novel lead candidates that enter into preclinical development, considerable resources are needed to identify impurities. LC/MS-based approaches provide integrated sample cleanup and structure analysis procedures for the rapid analysis of impurities. This advantage was demonstrated during the preclinical development of TAXOL . LC/MS played an important role for the identification of impurities contained in extracts and process intermediates from Taxus brevifolia and T. baccata biomass. Because drugs derived from natural sources often have a very diverse set of structural analogs, it is important to determine which... 

Raman spectroscopy in GaN has become a major tool for the convenient optical characterisation of doping (A,(LO) mode) and stress conditions (E2high mode) in heteroepitaxial material and device structures. Infrared absorption of local vibrational modes is starting to become an important tool for the chemical identification of impurities in GaN... 

---